[1]
Vynnychenko, O. and Moskalenko, Y. 2024. INFLAMMATORY MARKERS AS PREDICTORS OF EFFICACY OF BEVACIZUMAB AND TYROSINE KINASE INHIBITORS THERAPY IN METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS. Eastern Ukrainian Medical Journal. 12, 4 (Dec. 2024), 1007-1017. DOI:https://doi.org/10.21272/eumj.2024;12(4):1007-1017.